Alcohol consumption among patients diagnosed with genitourinary cancers

Fuente: Wiley Open Access
Guardado en:
Detalles Bibliográficos
Autores principales: Aidan Weitzner, Carlos Rivera Lopez, Joseph Cheaib, Michelle Higgins, Nirmish Singla
Formato: Artículo Open Access
Publicado: Wiley 2025
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867010510881292288
author Aidan Weitzner
Carlos Rivera Lopez
Joseph Cheaib
Michelle Higgins
Nirmish Singla
author_facet Aidan Weitzner
Carlos Rivera Lopez
Joseph Cheaib
Michelle Higgins
Nirmish Singla
Aidan Weitzner
Carlos Rivera Lopez
Joseph Cheaib
Michelle Higgins
Nirmish Singla
collection Wiley Open Access
contents Alcohol consumption among patients diagnosed with genitourinary cancers Aidan Weitzner Carlos Rivera Lopez Joseph Cheaib Michelle Higgins Nirmish Singla BJUI Compass AbstractObjectiveTo characterize alcohol consumption and binge‐drinking patterns among individuals with GU cancers (prostate, kidney, bladder and testicular) compared to a propensity‐matched cohort without cancer in a large, nationally diverse population.Materials and MethodsWe conducted a retrospective, cross‐sectional study utilizing data from the National Institutes of Health All of Us Research Program. Matching accounted for age, sex assigned at birth, smoking status, comorbidities and education/marital status. The primary outcome was self‐reported drinking frequency. The secondary outcomes were self‐reported binge‐drinking frequency and Alcohol Use Disorders Identification Test (AUDIT‐C) scores.ResultsDrinking and binge‐drinking among individuals with GU malignancy (N = 11 522) closely resembled those of matched controls (N = 47 747), with the majority (53%) consuming at least 2–4 drinks per month. There was no significant association between GU cancer diagnosis and increased drinking frequency (OR: 0.99; p = 0.65), binge‐drinking frequency (OR: 0.85; p: 0.055) or AUDIT‐C (OR: 0.99; p =0.65). Individuals diagnosed with kidney cancer had reduced odds of higher alcohol use (OR: 0.76; p < 0.001) and AUDIT‐C score (OR: 0.83; p < 0.001) compared to controls.ConclusionIn this large cohort, including traditionally underrepresented minorities, alcohol use was highly prevalent among those with GU malignancies. Drinking behaviours were similar to individuals without cancer, underscoring the need for integration of lifestyle‐focused interventions into survivorship care, as alcohol remains a common and modifiable behaviour with wide‐ranging health implications. 10.1002/bco2.70086 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/bco2.70086
format Artículo Open Access
id wiley_oa_10_1002_bco2_70086
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Alcohol consumption among patients diagnosed with genitourinary cancers
Aidan Weitzner
Carlos Rivera Lopez
Joseph Cheaib
Michelle Higgins
Nirmish Singla
BJUI Compass
Alcohol consumption among patients diagnosed with genitourinary cancers Aidan Weitzner Carlos Rivera Lopez Joseph Cheaib Michelle Higgins Nirmish Singla BJUI Compass AbstractObjectiveTo characterize alcohol consumption and binge‐drinking patterns among individuals with GU cancers (prostate, kidney, bladder and testicular) compared to a propensity‐matched cohort without cancer in a large, nationally diverse population.Materials and MethodsWe conducted a retrospective, cross‐sectional study utilizing data from the National Institutes of Health All of Us Research Program. Matching accounted for age, sex assigned at birth, smoking status, comorbidities and education/marital status. The primary outcome was self‐reported drinking frequency. The secondary outcomes were self‐reported binge‐drinking frequency and Alcohol Use Disorders Identification Test (AUDIT‐C) scores.ResultsDrinking and binge‐drinking among individuals with GU malignancy (N = 11 522) closely resembled those of matched controls (N = 47 747), with the majority (53%) consuming at least 2–4 drinks per month. There was no significant association between GU cancer diagnosis and increased drinking frequency (OR: 0.99; p = 0.65), binge‐drinking frequency (OR: 0.85; p: 0.055) or AUDIT‐C (OR: 0.99; p =0.65). Individuals diagnosed with kidney cancer had reduced odds of higher alcohol use (OR: 0.76; p < 0.001) and AUDIT‐C score (OR: 0.83; p < 0.001) compared to controls.ConclusionIn this large cohort, including traditionally underrepresented minorities, alcohol use was highly prevalent among those with GU malignancies. Drinking behaviours were similar to individuals without cancer, underscoring the need for integration of lifestyle‐focused interventions into survivorship care, as alcohol remains a common and modifiable behaviour with wide‐ranging health implications. 10.1002/bco2.70086 http://creativecommons.org/licenses/by/4.0/
title Alcohol consumption among patients diagnosed with genitourinary cancers
topic BJUI Compass
url https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.70086